Metropolitan Life Insurance Company (MetLife)’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio OCAT Stock Details OCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-31,487	Closed	-$265K	–	2582
2015 Q4	$265K	Buy	+31,487	New	+$211K	﹤0.01%	2046

Metropolitan Life Insurance Company (MetLife)'s OCAT Position: Q1 2016 in Review

Metropolitan Life Insurance Company (MetLife) sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 31,487 shares — an estimated $265K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in OCAT in Q4 2015 and held it in 1 quarter. The position peaked at $265K in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

Metropolitan Life Insurance Company (MetLife) reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 31,487 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $265K.
Metropolitan Life Insurance Company (MetLife) first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q4 2015 and held it in 1 quarter.
Metropolitan Life Insurance Company (MetLife)'s OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $265K in Q4 2015.
1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2016, filed 16 May 2016.